J. M. Huber Corporate Web Site Huber Engineered Materials Web Site
RxCipients
RxCipients Product Overview Safety Information for RxCipients Formulation Guidelines for RxCipients Test Results for RxCipients Detailed Techinical Information for RxCipients RxCipients Properties RxCipients Current News

Huber Engineered Materials

907 Revolution Street
Havre de Grace, MD  21078
USA

Contact Us
1-866-881-6480
FAX:410-939-7313

 

 
Speak to an Expert!
1-866-881-6480
  
 



Upon patient delivery, the robust oral dosage tablet begins to quickly disintegrate.

Within seconds, the tablet disintegrates into primary particles and the active is delivered.

RxCIPIENTS FM1000 - faster therapeutic action, better compliance, easy to formulate.

RxCIPIENTS® FM1000
Rapid disintegration technology for orally disintegrating tablets

Rapid disintegration technology is among the most exciting recent developments in the pharmaceutical industry. "Fast-melt" tablets deliver active ingredients to the body quicker ...  provide an oral dosage alternative for people who have difficulty swallowing tablets ... even boost compliance in taking medication.

But the rapid disintegration technologies now in the marketplace have their limitations. The high friability of these tablets demands special handling and packaging. Their manufacturing process requires pharmaceutical companies to give up control of their active ingredients to their manufacturing partners – and pay royalties on the finished product.

RxCIPIENTS  FM1000 excipients are changing all of that.

Developed by Huber Engineered Materials, a trusted name in calcium carbonate, silica, silicates and other specialty excipients, RxCIPENTS FM1000 is one new fast-melt technology with many, many benefits to formulators and brand managers:
 
Call today to learn more about RxCIPIENTS FM1000!  1-866-881-6480

  • Greater tablet durability. With a friability of less than 1 percent, tablets containing RxCIPIENTS FM1000 do not require special packaging. They can even be packaged in push-through blister packs or HDPE multidose containers.
  • Normal manufacturing. The stronger tablet enables pharmaceutical companies to manufacture fast-melt tablets in-house, with existing equipment. (You no longer have to send active ingredients to a special drug delivery system company for production.)
  • Greater tablet stability. Unlike other fast-melt excipients, RxCIPIENTS FM1000 is non-hygroscopic, so it prolongs shelf life of tablets.
  • Fast-melt that’s truly fast. RxCIPIENTS FM1000 will disintegrate in the mouth in 5 to 30 seconds.
  • Greater value. With RxCIPIENTS FM1000, you no longer have to pay royalties to other companies to produce a fast-melt tablet. And you can positively impact the life cycle management of your proprietary products by patent extension.

Formulation scientists who are bringing new products to the market or brand managers who are forecasting line extensions of existing products can begin test formulations with RxCIPIENTS FM1000 today!
Request Sample